Skip to main content
SpringerLink
Log in

Maligne Gliome – Radiotherapie

Malignant gliomas – radiotherapy

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

Postoperative radiotherapy is the treatment of choice for high grade gliomas and glioblastomas. The goal of the adjuvant radiotherapy is to improve local control and long term survival. The benefit of reirradiation for recurrent or progressive glioma is controversial. The therapeutic benefit of any radiotherapy intervention must be balanced by the risk of neurotoxicity and its impact on quality of life.

Zusammenfassung

Die postoperative Strahlentherapie der hochmalignen Gliome und Glioblastome führt zur Verbesserung der Lokalkontrolle und des Gesamtüberlebens. Eine Rezidivbestrahlung bei hochmalignen Gliomen und Glioblastomen kann im Einzelfall zu einer Lebensqualitätsverbesserung zum Einsatz kommen, wobei die Gefahr der Neurotoxizität und mit dem zu erwartenden Benefits abzuwägen wären.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Belka C, Budach W, Kortmann RD, Bamberg M (2001) Radiation induced CNS toxicity – molecular and cellular mechanisms. Br J Cancer 85: 1233–1239

    Article  PubMed  CAS  Google Scholar 

  • van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO et al.; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 radomised trial. Lancet 366: 985–990

    Article  PubMed  CAS  Google Scholar 

  • Bruckner JC, Michalak JC, Schomberg PJ (2001) Phase III trial of BCNU plus cisplatin versus BCNU alone, and standard radiation therapy versus accelerated radiation therapy in glioblastoma patients: NCCTG/SWOG reselts (abstract). Proc Am Soc Clin Oncol 20: 51a

    Google Scholar 

  • Cairncross G, Seiferheld W, Shaw E (2004) An Intergroup randomised controlled clinical trial of chemotherapy plus radiation versus radiation alone for pure and mixed anaplastic oligodentrogliomas: Initial report of RTOG 94–02 (abstract). Proc Am Soc Clin Oncol 23: 107a

    Google Scholar 

  • Castro JR, Phillips TL, Prados M (1997) Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 38: 257–261

    Article  PubMed  CAS  Google Scholar 

  • Castro JR, Saunders WM, Austin-Seymour MM (1985) A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: A Northern California Oncology Group study. Int J Radiat Oncol Biol Phys 11: 1795–1800

    PubMed  CAS  Google Scholar 

  • Chang CH, Horton J, Schoenfeld D (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52: 997–1007

    Article  PubMed  CAS  Google Scholar 

  • Choucair AK, Levin VA, Gutin PH (1986) Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 65: 654–658

    Article  PubMed  CAS  Google Scholar 

  • Coffey RJ, Lunsford LD, Taylor FH (1988) Suvival after stereotactic biopsy of malignant gliomas. Neurosurgery 22: 465

    PubMed  CAS  Google Scholar 

  • Combs SE, Gutwein S, Schulz-Ertner D (2004) Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: phase I/II study (abstract). Proc Am Soc Clin Oncol 23: 114a

    Google Scholar 

  • Fitzek MM, Thornton AF, Rabinov JD (1999) Accelerated fractionated proton/Photon irradiation to 90 cobalt Gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 91: 251–260

    PubMed  CAS  Google Scholar 

  • Galanis E, Bruckner J (2000) Chemotherapy for highgrade gliomas. Br J Cancer 82: 1371–1380

    PubMed  CAS  Google Scholar 

  • Grossman SA, O'Neill A, Grunnet M (2003) Phase III Study Comparing Three Cycles of Infuional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21: 1485–1491

    Article  PubMed  CAS  Google Scholar 

  • Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907–911

    PubMed  CAS  Google Scholar 

  • Humpl T, Bruhl K, Bohl J (1997) Cerebral haemorrhage in long-term survivors of childhood acute lymphoblastic leukaemia. Eur J Pediatr 156: 367–773

    Article  PubMed  CAS  Google Scholar 

  • Huncharek M (1998) Meta-analytic reevaluation of misonidazole in the treatment of high grade astrocytoma. Anticancer Res 18: 1935–1941

    PubMed  CAS  Google Scholar 

  • Huncharek M, Muscat J, Geschwind JF (1998) Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis. Anticancer Res 18: 4693–4697

    PubMed  CAS  Google Scholar 

  • Kiebert GM, Curran D, Aaronson NK (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: Results of a randomised Phase III trial on dose response (EORTC Trial 22844). Eur J Cancer 34: 1902–1909

    Article  PubMed  CAS  Google Scholar 

  • Klein M, Heimans JJ, Aaronson NK (2002) Effect of radiotherapy and other treatment-related factors on midterm to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360: 1361–1368

    Article  PubMed  CAS  Google Scholar 

  • Lutterbach J, Ostertag C (2005) What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma? J Clin Oncol 23: 2869–2870

    Article  PubMed  Google Scholar 

  • Nakagawa K, Aoki Y, Fujimaki T (1998) High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40: 141–146

    Article  Google Scholar 

  • Nathan S, Floyd (2004) Hypofractionated intensity-modulated Radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncoö Biol Phys 58: 721–726

    Article  Google Scholar 

  • Nelson DF, Diener-West M, Horton J (1988) Combined modality approach to treatment of malignant gliomas -reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 6: 279–284

    PubMed  Google Scholar 

  • Phillips C (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68: 23–26

    Article  PubMed  Google Scholar 

  • Roa W, Brasher PM, Bauman G (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospectiv radomized clinical trial. J Clin Oncol 22: 1583–1588

    Article  PubMed  CAS  Google Scholar 

  • Rosenzweig KE, Amols H, Ling CC (2003) New radiotherapy technologies. Semin Surg Oncol 21: 190–196

    Article  PubMed  Google Scholar 

  • Shapiro WR (1986) Therapy of adult malignant brain tumors: What have clinical trials taugh us? Semin Oncol 13: 38–45

    PubMed  CAS  Google Scholar 

  • Slotman BJ (1996) Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Radiat Oncol Biol Phys 34: 895–898

    Article  PubMed  CAS  Google Scholar 

  • Souhami L, Seiferheld MD, Brachman D (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93–05 protocol. Int J Radiat Oncol Biol Phys 60: 853–857

    Article  PubMed  Google Scholar 

  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K et al. (2005) European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl Med 352: 987–996

    Article  CAS  Google Scholar 

  • Surma-aho O, Niemela M, Vilkki J (2001) Adverse longterm effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56: 1285–1288

    PubMed  CAS  Google Scholar 

  • Valk PE, Dillon WP (1991) Radiation injury of the brain. AJNR Am J Neuroradiol 12: 45–49

    PubMed  CAS  Google Scholar 

  • Wallner KE, GalicichJH, Krol G (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405–1409

    PubMed  CAS  Google Scholar 

  • Young DF, Poster JB, Chu F, Nisce L (1974) Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 34: 1069–1076

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Radioonkologie, Kaiser Franz Josef Spital, SMZ-Süd, Wien, Austria

    Annemarie Schratter-Sehn

Authors
  1. Annemarie Schratter-Sehn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annemarie Schratter-Sehn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schratter-Sehn, A. Maligne Gliome – Radiotherapie. Wien Med Wochenschr 156, 342–345 (2006). https://doi.org/10.1007/s10354-006-0306-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-006-0306-5

Keywords

Schlüsselwörter

Search

Navigation